BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9321537)

  • 1. Differentiation therapy for acute promyelocytic leukemia.
    Fenaux P; Degos L
    N Engl J Med; 1997 Oct; 337(15):1076-7. PubMed ID: 9321537
    [No Abstract]   [Full Text] [Related]  

  • 2. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China.
    Wang ZY; Sun GL; Lu JX; Gu LJ; Huang ME; Chen SR
    Nouv Rev Fr Hematol (1978); 1990; 32(1):34-6. PubMed ID: 2349080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Tallman MS; Manji GA
    Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
    Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
    Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
    Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
    Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current therapy of acute promyelocytic leukemia using vitamin A derivatives].
    Löwenberg B; Budel LM
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):796-8. PubMed ID: 8487880
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
    Leeksma OC; van Oers MH; van der Schoot CE; Goudsmit R; von dem Borne AE
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):821-5. PubMed ID: 8487886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
    Sun GL
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of pediatric acute promyelocytic leukemia.
    Ribeiro R
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
    [No Abstract]   [Full Text] [Related]  

  • 20. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.